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Abstract
Background: Transthoracic echocardiography (TTE) is the standard method for the evaluation of the severity of
aortic stenosis (AS). Valve effective orifice area (EOA) measured by the continuity equation is one of the most
frequently used stenotic indices. However, TTE measurement of aortic valve EOA is not feasible or not reliable in a
significant proportion of patients. Cardiovascular magnetic resonance (CMR) has emerged as a non-invasive
alternative to evaluate EOA using velocity measurements. The objectives of this study were: 1) to validate a new
CMR method using jet shear layer detection (JSLD) based on acoustical source term (AST) concept to estimate the
valve EOA; 2) to introduce a simplified JSLD method not requiring vorticity field derivation.
Methods and results: We performed an in vitro study where EOA was measured by CMR in 4 fixed stenoses
(EOA = 0.48, 1.00, 1.38 and 2.11 cm
2) under the same steady flow conditions (4-20 L/min). The in vivo study
included eight (8) healthy subjects and 37 patients with mild to severe AS (0.72 cm
2 ≤ EOA ≤ 1.71 cm
2). All
subjects underwent TTE and CMR examinations. EOA was determinated by TTE with the use of continuity equation
method (TTECONT). For CMR estimation of EOA, we used 3 methods: 1) Continuity equation (CMRCONT); 2) Shear
layer detection (CMRJSLD), which was computed from the velocity field of a single CMR velocity profile at the peak
systolic phase; 3) Single plane velocity truncation (CMRSPVT), which is a simplified version of CMRJSLD method. There
was a good agreement between the EOAs obtained in vitro by the different CMR methods and the EOA predicted
from the potential flow theory. In the in vivo study, there was good correlation and concordance between the
EOA measured by the TTECONT method versus those measured by each of the CMR methods: CMRCONT (r = 0.88),
CMRJSLD (r = 0.93) and CMRSPVT (r = 0.93). The intra- and inter- observer variability of EOA measurements was 5 ±
5% and 9 ± 5% for TTECONT, 2 ± 1% and 7 ± 5% for CMRCONT, 7 ± 5% and 8 ± 7% for CMRJSLD, 1 ± 2% and 3 ± 2%
for CMRSPVT. When repeating image acquisition, reproducibility of measurements was 10 ± 8% and 12 ± 5% for
TTECONT, 9 ± 9% and 8 ± 8% for CMRCONT, 6 ± 5% and 7 ± 4% for CMRJSLD and 3 ± 2% and 2 ± 2% for CMRSPVT.
Conclusion: There was an excellent agreement between the EOA estimated by the CMRJSLD or CMRSPVT methods and:
1) the theoretical EOA in vitro, and 2) the TTECONT EOA in vivo. The CMRSPVT method was superior to the TTE and other
CMR methods in terms of measurement variability. The novel CMR-based methods proposed in this study may be
helpful to corroborate stenosis severity in patients for whom Doppler-echocardiography exam is inconclusive.
Background
Transthoracic echocardiography (TTE) is the standard
method for the evaluation of the severity of aortic stenosis
(AS) [1]. One of the parameters that is most frequently
used to assess AS severity is the aortic valve effective
orifice area (EOA) determined by the continuity equation
method. However, TTE measurements of EOA may not
be feasible or reliable in a significant proportion of patients
due to patients’ characteristics, technical limitations or
users’ experience [1-4]. When the Doppler-echocardio-
graphic measurements are not feasible or are discordant, it
is important to confirm the stenosis severity with other,
ideally non-invasive, diagnostic modalities.
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invasive, non-ionizing technique, with excellent temporal
and spatial resolutions and superior measurement repro-
ducibility. CMR may be used to measure the geometric
(i.e. anatomic) orifice area (GOA) of the stenotic valve by
planimetry [5-7]. However, the GOA is inferior to EOA to
predict hemodynamic and clinical outcomes and its esti-
mation may be difficult in heavily calcified valves [8,9].
CMR may be used to measure the EOA via the continuity
equation. Several studies have shown that EOA obtained
using CMR correlates well with the EOA obtained by TTE
[10-13]. However, in a recent study performed by our
group [13], we found that the resulting concordance
between TTE and CMR for the EOA computed using the
continuity equation is, in large part, due to the fact that
the underestimation of ALVOT by TTE is compensated by
an overestimation of VTILVOT. We also discussed the
potential variability in EOA values obtained using the con-
tinuity equation both by TTE and CMR as a result of the
multitude of parameters to be measured. There is thus an
important need for the development and validation of new
simpler, more reproducible but still highly accurate CMR
methods to estimate the EOA in AS patients. In a previous
in vitro study, using particle image velocimetry measure-
ments, we have shown that EOA can be directly deter-
mined using velocity measurements downstream of the
stenosis and the application of acoustical source term con-
cept (AST) [14]. Briefly, the fundamental idea behind this
concept is that the flow jet created by the stenotic valve
generates acoustic noise and the major sources of this
sound generation can be determined by computing the
acoustical source term. The acoustical source term is a
function of the local velocity and the vorticity (a measure
of the rate of rotation of fluid elements). Applied to AS,
this means that the shear layer surrounding the orifice jet
is a major source of acoustic noise. As a consequence, the
limits of the jet-like zone downstream of the orifice, and
therefore the EOA, can be determined using the AST
maps without requiring the knowledge of the flow rate
magnitude. In our previous in vitro study, we used particle
image velocimetry, an optical technique that cannot be
applied to the human body. Interestingly, it has been
demonstrated that particle image velocimetry and phase-
contrast velocity measure the same velocity map [15-19].
We can then hypothesize that the EOA of an AS could be
determined using AST maps computed from CMR velo-
city measurements.
The objectives of this study are: 1) to extend the pre-
vious method for the determination of the EOA based on
acoustical source term to velocity measurements obtained
by CMR (here called Jet Shear Layer Detection method
(JSLD)); 2) to introduce a simplified JSLD method not
requiring vorticity field derivation. Both of the previously
mentioned approaches require only a single velocity
measurement (downstream of the AS) to determine the
EOA. These new methods were evaluated both in vitro
and in vivo. In the in vitro study, the EOAs determined by
these new CMR methods were compared to the theoreti-
cal EOA predicted using the potential flow theory,
whereas, in the in vivo study, they were compared to those
obtained by standard TTE and CMR methods based on
continuity equation.
Methods
In vitro study
The in vitro setup consisted of controllable pump generat-
ing steady flow (4 to 20 L/min), a compatible module with
CMR magnet and a fluid reservoir. Four fixed circular ste-
noses (sharp-edge orifices with EOA = 0.48, 1.00, 1.38 and
2.11 cm
2, with small aspect-ratios) were tested under the
same steady flow conditions. Testing sharp-edge orifices,
as models of fixed aortic stenosis, is a realistic approach
since two (calcified thickened valve and thin fused valve)
among the four more common morphological shapes of
aortic stenoses can be represented by sharp-edge orifices
[20]. Flow rate was measured with a Transonic flow probe
16A415 (accuracy: ± 4%, on full scale) connected to a
T206 Transonic flow meter (Transonic, Ithaca, NY, USA)
and was calibrated using a standard flow measuring
method. A 65% saline and 35% glycerine (in volume) solu-
tion at room temperature was used to mimic viscous pro-
prieties of blood at 37°C [21]. The use of such Newtonian
fluid is justified in the context of aortic valve and ascend-
ing aorta [22-24]. A similar approach was used by others
[25-27].
Each orifice was placed at the center of a clinical 3 Tesla
magnetic resonance scanner with a dedicated phase-array
receiver coil (Achieva, Philips Medical Systems, Best, the
Netherlands). An ECG patient simulator (model 214B,
DNI Nevada Inc, USA) was used to synchronize scanner
gating. A standard examination was performed by initial
acquisition of images in long-axis and short-axis planes for
planning. Phase-contrast retrospective examination was
performed in short-axis planes 12 mm upstream and
10 mm downstream of to the orifice plane. Imaging para-
meters consisted of: TR/TE of 17.99/3.97 ms, flip angle
15°, 50 phases, pixel spacing 1.25 mm, slice thickness
10 mm, acquisition matrix of 256 × 256 and encoding
velocity (2 × maximal velocity).
A custom-made research application was developed
using Matlab software (Mathworks, Natick, Ma, USA) to
process and analyze in vitro and in vivo images [28].
In vivo study
Patient population
Eight (8) healthy subjects and 37 patients with mild to
severe AS (0.72 cm
2 ≤ EOA ≤ 1.71 cm
2)w e r ei n c l u d e d
in this study. Exclusion criteria were: age < 21 years, LV
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Page 2 of 12ejection fraction < 50%, atrial fibrillation, mild mitral or
aortic regurgitation, poor TTE imaging quality and stan-
dard contra-indications to magnetic resonance imaging.
All patients provided written informed consent under
the supervision of the institutional review board. AS
severity classification followed American College of Car-
diology/American Heart Association (ACC/AHA) guide-
lines [1]: mild (1.5 cm
2 <E O A≤ 2.0 cm
2), moderate
(1.0 cm
2 < EOA ≤ 1.5 cm
2) and severe (EOA ≤ 1.0 cm
2).
Effective orifice area determination using transthoracic
echocardiography
Transthoracic Doppler echocardiography (TTE) exami-
nations were performed and analyzed by two experi-
enced echocardiographers. TTE measurements were
performed according to the American Society of Echo-
cardiography guidelines [2] and included: LVOT dia-
meter, LVOT flow velocity by pulsed-wave Doppler,
transvalvular aortic jet velocity by continuous-wave
Doppler and valve EOA using continuity equation [1]:
TTECONTEOA = SVLVOT/VTIAo = (VTILVOT × ALVOT)/VTIAo (1)
Where SVLVOT i st h es t r o k ev o l u m em e a s u r e di nt h e
LVOT, ALVOT is the cross-sectional area of the LVOT
calculated assuming a circular shape; and VTILVOT and
VTIAo a r et h ev e l o c i t y - t i m ei n t e g r a l so ft h eL V O Ta n d
transvalvular flow, respectively.
Cardiovascular magnetic resonance
CMR studies were performed 2 to 4 weeks after TTE
with patients in comparable hemodynamic state (Heart
rate at TTE = 66 ± 11 bpm vs. CMR = 67 ± 12 bpm, p =
NS). Imaging was performed with a clinical 1.5 Tesla Phi-
lips Achieva scanner operating release 2.6 level 3 and
dedicated phased-array cardiac coil during successive
end-expiratory breath-holds (Philips Healthcare, Best,
The Netherlands). Imaging of cardiac function was per-
formed by SSFP technique at 30 phases per cardiac cycle,
with vectorcardiographic gating in 8-14 parallel short-
axis, 2-chamber, 4-chamber, and 2 orthogonal LVOT
planes (8 mm thickness, 0 mm gap). Typical parameters
included TR/TE of 3.4/1.2 ms, flip angle 40°, NEX of 1,
yielding in-plane spatial resolution of 1.6 × 2 mm. In
addition, through-plane phase-contrast imaging was per-
formed in the LVOT at 12 mm upstream from the aortic
valve annulus (reference: 0 mm) and in the ascending
aorta at +10 mm downstream of the annulus (Figure 1A).
CMR imaging parameters consisted of: TR/TE of 4.60-
4.92/2.76-3.05 ms, flip angle 15°, 24 phases, pixel spacing
1.32-2.07 mm, slice thickness 10 mm and acquisition
matrix of 256 × 208. For each patient, peak aortic jet
velocity measured by TTE was used to define CMR
encoding velocity (CMR encoding velocity = (1.25 to 1.5)
× peak jet velocity).
EOA determination using CMR
Effective orifice area using continuity equation CMR
images acquisitions and analyses were performed by
investigators blinded to clinical and TTE results. The
CMR-derived EOA (CMRCONT) was calculated using
continuity equation [8,10,12]:
CMRCONTEOA = SVCMR/VTIAo (2)
Figure 1 Image planes used for CMR measurements. The flow velocity map was acquired at two image planes: -12 mm upstream from
aortic valve plane (used as the 0 mm reference) and +10 mm downstream of the aortic valve plane (Panel A). The cross-sectional area of the
LVOT is measured at the -12 mm position. Panel B shows the instantaneous peak velocity (Vpeak) measurements in the cross-sectional aortic area
at +10 mm. Panel C shows the instantaneous (Q) flow measurement at LVOT.
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velocities measured 12 mm upstream from the aortic
valve (Simpson’s rule was used to integrate flow during
systole, Figure 1B) and VTIAo (Figure 1C) is the velocity-
time integral of the peak aortic flow velocity measured
10 mm downstream of the aortic valve during systole.
Effective orifice area by Shear Layer Detection This
new method is based on the acoustical source term
( A S T )c o m p u t e df r o mt h ev e l o c i t yf i e l d[ 1 4 , 2 9 ] .B r i e f l y ,
flow disturbance and separation downstream of an aor-
tic stenosis produce high vorticity field which is
responsible for sound generation [24]. This concept of
sound generated by flow is mainly based on the vortex
sound theory developed first by Lighthill [30] and then
by Powell [31] and Howe [32]. In this theory, the term
[∇ (ωΛV)], where ∇ is the nabla operator, ω is the vor-
ticity field, and V is the velocity field, is called the
acoustical source term (AST) and is responsible for the
sound generated by unsteady fluid motion. This
method provides an accurate and simple way of separ-
ating the jet-like zone from the recirculation zone right
downstream of the stenotic valve and defines then the
area of the vena contracta, i.e. the EOA [14] (Figure 2).
This is due to the amplification of the vorticity by the
magnitude of the local velocity. Only a single velocity
profile at the peak systolic phase in the ascending aorta
at 10 mm from aortic valve plane is necessary to deter-
mine the EOA with this method. This velocity profile
was normalized with respect to peak velocity and then
used to compute vorticity and AST shear layers profiles
(Figure 2B and 2C). The CMRJSLD EOA was measured
by a semi-automated algorithm that detects the peaks
of normalized AST profiles corresponding to maximal
noise production due to vorticity [14] (Figure 2D and
3A). An animation showing step-by-step how AST is
determined from CMR velocity maps is included as
Additional file 1.
Effective orifice area using single plane velocity trun-
cation (SPVT) measurement method The same normal-
ized velocity profile at peak systole used for CMRJSLD
EOA computation is used for CMRSPVT EOA determina-
tion. However, instead of systematically computing vorti-
city and AST shear layer profiles (potentially resulting in
truncation errors), the velocity profile is simply truncated
at a threshold value of 0.65 and the area of the top surface
obtained is considered to be the EOA. This threshold was
obtained by a systematic analysis of AST shear layer pro-
files from the in vitro results (Figure 4). The same value
was used in vivo for all patients (Figure 3B). A standalone
application for computing the proposed EOA CMR
Figure 2 Effective orifice area computed using shear layer detection method (JSLD). Effective orifice area computed using jet shear layer
detection method (JSLD). Panel (A) shows flow streamlines through an orifice (geometric orifice area [GOA] = 1.66 cm
2 and effective orifice area
[EOA] = 1.00 cm
2). Dashed line represents a plane crossing the vena contracta (≈ 10 mm from the orifice). Panel (B) shows normalized velocity
map at the vena contracta. Panel (C) shows AST shear layers computed from (B), JSLD identifies the inflexion points from the velocity profile
corresponding to noise production, shear layers from vorticity and separation regions at the vena contracta position lead to EOA estimation
(blue circle with transparency). Panel (D) shows the correspondence between normalized velocity profiles and normalized AST profiles, gray lines
indicate the corresponding voxel on EOA identified shear layer
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Page 4 of 12Figure 3 Shear layer detection (JSLD) and single plane velocity truncation (SPVT) methods for the determination of EOA by CMR. The
velocity map is isolated along cardiac cycle by a semi-automatic detection of vessel borders. Once the velocity map at peak systole is isolated,
both CMRJSLD and CMRSPVT methods can be applied. Panel A describes the CMRJSLD method: i) the isolated velocity map is used to compute
normalized vorticity map and acoustical source term map, which is an amplification of vorticity map by local velocity magnitude; ii) a semi-
automated algorithm that detects the peaks of AST shear layers corresponding to maximal noise production due to vorticity; iii) pixels inside the
computed contour area are counted to estimate valve EOA. Panel B describes CMRSPVT method: i) the isolated velocity map is normalized with
respect to its maximal velocity; ii) a threshold of 0.65 is used to truncate the normalized velocity profile; iii) pixels inside the threshold area are
counted to estimate valve EOA. These algorithms could be also applied throughout systole.
Figure 4 Example of EOA determination using CMRJSLD and CMRSPVT methods in the in vitro study. Panel A shows the isolated velocity
map of a rigid plate orifice with GOA = 1.65 cm
2 and a theoretical EOA = 1.00 cm
2. Panel B shows the EOA estimation using CMRJSLD method
and panel C shows the EOA estimation using CMRSPVT method. B and C images are normalized from their maximal magnitude.
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concordia.ca/~kadem/Research.html.
Measurement variability To evaluate intra- and inter-
observer variability related to image analysis by CMR and
TTE, the measurements of EOA, using all methods, were
repeated in a subset of 15 studies (11 AS patients and 4
control subjects) by two blinded observers with the use
o ft h es a m es e to fT T Ea n dC M Ri m a g e s .T of u r t h e r
evaluate the intra- and inter- observer- variability related
to image acquisition and analysis by TTE and CMR, 5 AS
patients were imaged twice within 4 weeks (including
image acquisition and analysis).
Statistical analyses Results are expressed as mean ± SD.
Paired 2-tailed Student’s t-test was used to compare EOA
measures. Correlations and agreement between CMR and
TTE EOA measurements were assessed with the use of
Pearson’s correlation and Bland-Altman methods, respec-
tively. Statistics were performed with SPSS 17 (SPSS, Chi-
cago, IL).
Results
In vitro study
Figure 5 shows the results of EOA as a function of flow
for the different orifices tested. EOA determined by
CMRCONT,C M R JSLD and CMRSPVT methods were com-
pared to the theoretical EOA predicted by the potential
flow theory for sharp-edge orifices: EOA = 0.61 × GOA,
where GOA is the geometric orifice area and the 0.61 is
the contraction coefficient in the situation of sharp-edge
orifices. Absolute and mean relative errors are reported
in Table 1.
In vivo study
Thirty-seven patients with mild to severe AS (71% men,
age 61 ± 18 years) and eight healthy subjects (63% men,
age 34 ± 8 years) underwent TTE and CMR studies.
Valve morphology was bicuspid in twelve of the 37 (32%)
AS patients and was indeterminate in 3 patients (8%)
using TTE evaluation. Patient characteristics are given in
Table 2.
Overall, there was a good correlation and concordance
between the EOAs obtained by TTECONT and those
obtained by the 3 CMR methods. The average EOA was
1.46 ± 0.64 cm
2 for TTECONT, 1.69 ± 0.73 cm
2 for
CMRCONT, 1.57 ± 0.90 cm
2 for CMRJSLD and 1.58 ± 0.94
cm
2 for CMRSPVT. When compared to the EOA mea-
sured by TTECONT, the results of correlation and agree-
ment were r = 0.88, bias = +0.23 cm
2 and agreement
Figure 5 Effective orifice areas obtained by the different CMR methods (continuity equation, JSLD, and SPVT) in the in vitro study
under steady flow conditions. Panels A, B, C, and D show the results obtained with an orifice of EOA of 0.48, 1.00, 1.38 and 2.11 cm
2,
respectively. The dashed line represents the EOA predicted by the potential flow theory (EOA = 0.61 × GOA); where GOA is the geometrical
orifice area.
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2 for CMRCONT (Figure 6A and
6B); r = 0.93, bias = +0.12 cm
2 and agreement limits:-
0.62 and +0.86 cm
2 for CMRJSLD (Figure 6C and 6D); r =
0.93, bias = +0.10 cm
2 and agreement limits:-0.57 and
+0.77 cm
2 for CMRSPVT (Figure 6E and 6F). There was
also a good agreement between CMRSPVT and CMRCONT
( r=0 . 8 8 ,b i a s=- 0 . 1 3c m
2 and agreement limits:-0.90
and +0.65 cm
2; Figure 6G and 6H).
In terms of clinical implications, seventeen (37%)
patients had a change in AS severity class when using the
EOA determined by CMRCONT instead of TTECONT:
three (6%) patients were re-classified in a more severe
class and 14 (31%) in a less severe class. When using
EOA determined by CMRJSLD: nineteen (42%) patients
had a change in AS severity: six (13%) patients were re-
classified in a more severe class and 13 (29%) in a less
severe class. When using the EOA determined by
CMRSPVT: twenty-one (46%) patients had a change in AS
severity: eight (18%) patients were re-classified in a more
severe class and 13 (29%) in a less severe class. Impor-
tantly, the severity was changed from severe to moderate
in 2 patients with CMRCONT and in 3 patients with
CMRJSLD or CMRSPVT.
Measurement variability
The intra- and inter- observer variability of EOA measure-
ments was 5 ± 5% and 9 ± 5% for TTECONT,2±1 %a n d
7 ± 5% for CMRCONT, 7 ± 5% and 8 ± 7% for CMRJSLD,
1 ± 2% and 3 ± 2% for CMRSPVT. When repeating image
acquisition, reproducibility of measurements was 10 ± 8%
and 12 ± 5% for TTECONT, 9 ± 9% and 8 ± 8% for
CMRCONT,6±5 %a n d7±4 %f o rC M R JSLD and 3 ± 2%
and 2 ± 2% for CMRSPVT, for observer one and two
respectively.
Discussion
Contemporary clinical evaluation of the AS severity is
mainly based on the TTE measurements of valve EOA,
which corresponds to the minimal cross-sectional area of
the transvalvular flow jet downstream of the aortic valve.
However, TTE measurements are sometimes not feasible
or might lead to discordant results. In particular, the
situation where the EOA measured by TTE is in the
severe range (e.g. 0.8 cm
2) but the gradient (or other ste-
notic indices) is in the moderate range (i.e. 30 mmHg)
poses a challenge for the treating physician, especially if
the patient is symptomatic. This discordance may be due
to measurement errors, small body size, or low flow state
conditions [33,34]. Low flow state conditions may occur
Table 1 Absolute and mean relative error for the determination of the EOA in the in vitro study
Effective Orifice area (cm
2) Method Absolute error (cm
2) Mean relative error (%)
0.48 CMRCONT 0.10 ± 0.02 23 ± 5
CMRJSLD 0.02 ± 0.01 4 ± 3
CMRSPVT 0.02 ± 0.004 5 ± 1
1.00 CMRCONT 0.03 ± 0.01 3 ± 1
CMRJSLD 0.04 ± 0.04 4 ± 4
CMRSPVT 0.05 ± 0.02 5 ± 2
1.38 CMRCONT 0.09 ± 0.02 6 ± 2
CMRJSLD 0.04 ± 0.03 3 ± 2
CMRSPVT 0.04 ± 0.02 3 ± 1
2.11 CMRCONT 0.06 ± 0.03 3 ± 2
CMRJSLD 0.03 ± 0.03 1 ± 1
CMRSPVT 0.08 ± 0.07 4 ± 3
All orifices CMRCONT 0.07 ± 0.04 9 ± 9
CMRJSLD 0.03 ± 0.03 3 ± 3
CMRSPVT 0.05 ± 0.04 4 ± 2
The reference value is the EOA predicted using potential flow theory (EOA = Cc × GOA), where GOA is the geometrical orifice area and Cc is the contraction
coefficient that is = 0.61 (i.e. value for Cc for harp-edge orifices with small aspect ratio). CMRCONT: EOA determined using continuity equation; CMRJSLD: EOA
determined using shear layer detection (JSLD) based on acoustical source term concept; CMRSPVT: EOA determined using single plane velocity truncation (SPVT)
method.
Table 2 Patient Characteristics
Age (years) 61 ± 18
Male gender n (%) 32 (71)
Heart rate (bpm) 66 ± 11
Weight (kg) 76 ± 14
Height (cm) 169 ± 10
Body surface area (m
2) 1.88 ± 0.21
Body mass index (kg/m
2)2 6 ± 4
Valve morphology
Tricuspid n (%) 30 (67)
Bicuspid n (%) 12 (27)
Indeterminate n (%) 3 (6)
The table shows the mean ± SD or number of patients and percentage.
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also in the context of preserved LVEF. This later condi-
tion, named paradoxical low flow AS [35] occurs in
patients with pronounced concentric LV remodelling,
small LV cavities and impaired LV filling and is charac-
terized by reduced pump function and thus reduced
stroke volume and transvalvular flow rate despite pre-
served LVEF. In patients with low flow states, the trans-
valvular gradient, which is highly flow-dependent, may be
pseudo-normalized and may thus underestimates the
severity of AS.
In these situations where the TTE measurements are
not feasible or discordant, it is necessary to use
another imaging modality to determine the actual AS
severity and to confirm or infirm the results of TTE.
This information is crucial for therapeutic decision
making.
In the present study, we proposed a new method based
on direct determination of the valve EOA from a single
velocity measurement downstream of the stenosis using
AST jet shear layer detection. The results of this study
reveal an excellent agreement between the EOA esti-
mated by this new method and the EOA predicted in
vitro by the potential flow theory or measured in vivo by
TTE with the continuity equation method. We also pro-
posed a simplified version of the JSLD method, which
Figure 6 Correlation and agreement between the EOAs obtained in vivo by the different CMR and TTE methods. Panels A, C, E, and G
show the Pearson correlation plots of CMRCONT vs. TTECONT, CMRJSLD vs. TTECONT, CMRSPVT vs. TTECONT, and CMRSPVT vs. CMRCONT, respectively. The
dashed line is the regression line and the solid line is the identity line. Panels B, D, F, and H show the Bland-Altman plots of CMRCONT vs.
TTECONT, CMRJSLD vs. TTECONT, CMRSPVT vs. TTECONT, and CMRSPVT vs. CMRCONT. The solid line is the mean bias and dashed lines are ± 1.96
standard-deviations lines. Non filled circles are healthy subjects.
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(included in the definition of the AST).
The main advantage of these methods is that they are
simple and require only one image plane and one mea-
surement to calculate the EOA. This minimal requirement
for the determination of the EOA contributes to the
reduction of the errors and may, at least in part, explain
why they have better inter- and intra- observer variability
compared to the other TTE or CMR methods. It is also
important to note that Yap et al. [12] have previously
introduced a method requiring a single measurement
plane by measuring the stroke volume at the level of the
aorta, instead of the LVOT. The main originality and
interest of the new methods we are proposing in our
paper is that the determination of the EOA only requires a
single plane velocity measurement and moreover it does
not require measurement of stroke volume.
The new simple and reliable methods described in the
present study may thus help to confirm stenosis severity
and guide therapeutic management. In this regard,
F i g u r e7s h o w st h ec a s eo fasymptomatic patient who
had a discordance between EOA (0.95 cm
2) and mean
gradient (32 mmHg) at TTE, thus raising uncertainty
about the actual severity of the stenosis. CMRSPVT con-
firmed that the EOA is in the severe range (1.00 cm
2)
and the patient was referred to surgery, which revealed
a heavily thickened and calcified valve.
Sondergaard et al. [7,36] have introduced a similar
approach as the one proposed in the present study to
determine the GOA (not the EOA) of a stenotic valve
using the velocity map. This was achieved by performing
the measurements at the level of the aortic valve and by
using a threshold of 0.5 × maximal velocity. Their
method was validated in vitro and they found a very good
concordance with the actual geometric area of the rigid
circular orifices used in their study. In the present study,
the purpose of the new proposed methods is to estimate
the EOA. Hence, an optimal location of the CMR single
plane measurement is of primary importance in order to
minimize volume averaging errors. For all the cases
investigated in this study, the measurements were per-
formed 10 mm downstream of the aortic valve annulus.
This choice was motivated by the results obtained
through numerical simulations showing that for a rigid
circular orifice of effective orifice area of 1.00 cm
2 (cut-
off value of EOA for severe AS), performing the measure-
ments with a slice thickness of 10 mm (averaging the
velocity profiles within the slice thickness) at 10 mm
downstream of the valve annulus does not yield to signifi-
cant differences compared to measurements performed
exactly at the location of the vena contracta position (Fig-
ures 8 and 9). This distance is in agreement with other in
vitro tests performed under pulsatile flow conditions
[37]. It is important however to note that inadequate
Figure 7 Example of a patient with discordant echocardiography findings in whom stenosis severity was corroborated by the
measurement of EOA with the use of CMRSPVT. EOA: effective orifice area; SV: stroke volume; TPG: transprosthetic gradient.
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plane, will lead to an overestimation of the EOA by all
CMR methods: EOA based on the continuity equation,
JSLD method and SPVT method. The resulting overesti-
mation, compared to the TTE derived EOA, is propor-
tional to the ratio of aortic cross-sectional area/EOA, or
to valve energy loss coefficient.
Study limitations
The main limitations of this study are: i) small number
of patients with severe AS; ii) absence of gold-standard
reference method for EOA measurement in vivo. The
determination of valve EOA can be performed by cathe-
terization using the Gorlin formula. However, this
method is invasive and not without risk for the patients
[38]. Furthermore, it has important limitations and thus
cannot be considered as a gold standard reference
method [39].
Another limitation of this study is the potential effect
of aliasing on the EOA determined by all the methods.
Aliasing may affect flow measurements and EOA pro-
posed methods leading to a systematic overestimation of
Figure 8 Vena contracta position estimated from numerical simulations. Three-dimensional numerical simulations of a steady flow (20 l/
min) through an orifice plate with an EOA = 1.00 cm
2 were performed using a computational fluid dynamics package (Fluent, ANSYS,
Canonsburg, PA, USA) package. More than 10
6 elements were used. Turbulent flow was modelled using a standard k-ω model. The figure shows
the maximum velocity along the centre of orifice from -10 cm to +10 cm. Zoomed region shows the region of vena contracta downstream of
the sharp-edge orifice.
Figure 9 Vena contracta region during systole on a severe aortic stenosis (EOA = 0.88 cm
2). Vena contracta region (in red) remained
almost constant closer to the aortic valve. Vena contracta exact position was 13 mm from the aortic valve at peak systole. Vena contracta region
was defined using JSLD method.
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will not be affected by aliasing as long as the velocity
profile is not truncated below its inflexion points. This
represents an extreme case in clinical practice. Finally, it
should be mentioned that some unwrapping algorithms
[40-43] allow the correction of aliasing and it is gener-
ally avoided in clinical practice.
Conclusion
There was an excellent agreement between the EOA
estimated by the CMRSPVT method and: 1) the theoreti-
cal EOA in vitro, and 2) the TTECONT EOA in vivo.
Furthermore, the CMRSPVT method was superior to the
other TTE or CMR methods in terms of measurement
variability. This new simple and non-invasive method
may be helpful to corroborate stenosis severity in
patients for whom Doppler-echocardiography exam is
inconclusive.
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